Organon announced an agreement with Lilly to become the sole distributor and promoter for the migraine medicines Emgality® and RAYVOW™ in Europe.
Organon, a global healthcare company with a focus on women’s health, announced an agreement with Eli Lilly and Company (Lilly) to become the sole distributor and promoter for the migraine medicines Emgality® (galcanezumab) and RAYVOW™(lasmiditan) in Europe. Emgality, a humanized…